Bristol Myers Squibb on Thursday posted better-than-expected fourth quarter earnings, but said its 2025 revenue would fall ...

By Michael Erman and Sriparna Roy (Reuters) -Bristol Myers Squibb on Thursday said its 2025 revenue would fall more sharply ...

Ed: As usual, a disappointing lack of ambition from the senior management to push hard for promotion. They blame the transfer ...

Discover how an innovative NHS program is breaking barriers to employment in Bristol, supporting over 130 individuals to find ...

Travellers flying from Bristol Airport have been issued with a warning over car parking. North Somerset Council's Trading ...

Bristol Myers Squibb Co. released sales and profit forecasts for 2025 below Wall Street’s expectations — a sign the company’s ...

Independent businesses along one of Bristol's most famous streets, which is subject to a £15 million transformation scheme, ...

The drugmaker Bristol Myers Squibb has been a standout among its big pharma peers over the past six months, scoring a ...

Bristol Myers Squibb reported strong fourth-quarter earnings but its outlook for 2025 failed to meet expectations.

(Reuters) -Bristol Myers Squibb on Thursday posted better-than-expected fourth-quarter earnings, but said its 2025 revenue ...

The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face ...

Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's "Halftime Report" to explain why he's selling Bristol Myers so ...